Descending thoracic aortic aneurysm repair with the aid of partial cardiopulmonary bypass: heparin-coated circuits versus nonheparin-coated circuits

Artif Organs. 2005 Apr;29(4):300-5. doi: 10.1111/j.1525-1594.2005.29051.x.

Abstract

Background: We have performed descending thoracic aortic aneurysm repairs with partial cardiopulmonary bypass, including heparin-coated circuits. The aim of this study was to evaluate (i) the impact of partial cardiopulmonary bypass on distal organ function and surgical outcomes; and (ii) the effectiveness of using heparin-coated circuits for preventing bleeding complications.

Methods: From July 1980 to June 2004, 309 patients underwent descending thoracic aortic aneurysm repairs using partial cardiopulmonary bypass. Their mean age was 61 years (range 19-81 years). One hundred of the 309 patients underwent repair of descending thoracic aortic aneurysm with heparin-coated circuits. Blood data for renal and hepatic function were collected on the day before the operation and postoperative days.

Results: The in-hospital mortality was 15%. Distal organ dysfunction included spinal cord dysfunction in 2 patients (0.7%) and renal failure necessitating hemodialysis in 15 patients (5%, 15/297: excluded 12 dialysis patients). Multivariate analyses showed that preoperative hemodialysis and emergency operation were risk factors for operative mortality and that emergency operation was a risk factor for requiring hemodialysis. Renal and hepatic function normalized by 2 weeks after surgery. There were no significant differences between the heparin-coated group and nonheparin-coated group in amounts of packed red cells, fresh frozen plasma, and platelets transfused during the procedures.

Conclusions: Our data showed that partial cardiopulmonary bypass is a safe and effective method for distal perfusion. Using this technique, descending thoracic aortic aneurysm repair can be performed with acceptable mortality and morbidity. However, the superiority of heparin-coated circuits over nonheparin-coated ones was not proved.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alanine Transaminase / blood
  • Anticoagulants / administration & dosage*
  • Aortic Aneurysm, Thoracic / blood
  • Aortic Aneurysm, Thoracic / surgery*
  • Cardiopulmonary Bypass / methods*
  • Creatinine / blood
  • Female
  • Heparin / administration & dosage*
  • Humans
  • Kidney / physiopathology
  • Liver / physiopathology
  • Male
  • Middle Aged
  • Perfusion / instrumentation*
  • Postoperative Hemorrhage / prevention & control*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Heparin
  • Creatinine
  • Alanine Transaminase